STAAR Surgical Total Current Liabilities 2010-2024 | STAA
STAAR Surgical total current liabilities from 2010 to 2024. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
STAAR Surgical Annual Total Current Liabilities (Millions of US $) |
2023 |
$65 |
2022 |
$52 |
2021 |
$49 |
2020 |
$41 |
2019 |
$34 |
2018 |
$28 |
2017 |
$19 |
2016 |
$21 |
2015 |
$18 |
2014 |
$16 |
2013 |
$18 |
2012 |
$18 |
2011 |
$14 |
2010 |
$13 |
2009 |
$27 |
STAAR Surgical Quarterly Total Current Liabilities (Millions of US $) |
2024-09-30 |
$66 |
2024-06-30 |
$66 |
2024-03-31 |
$63 |
2023-12-31 |
$65 |
2023-09-30 |
$57 |
2023-06-30 |
$54 |
2023-03-31 |
$47 |
2022-12-31 |
$52 |
2022-09-30 |
$45 |
2022-06-30 |
$47 |
2022-03-31 |
$41 |
2021-12-31 |
$49 |
2021-09-30 |
$47 |
2021-06-30 |
$42 |
2021-03-31 |
$36 |
2020-12-31 |
$41 |
2020-09-30 |
$34 |
2020-06-30 |
$32 |
2020-03-31 |
$30 |
2019-12-31 |
$34 |
2019-09-30 |
$30 |
2019-06-30 |
$29 |
2019-03-31 |
$28 |
2018-12-31 |
$28 |
2018-09-30 |
$28 |
2018-06-30 |
$25 |
2018-03-31 |
$26 |
2017-12-31 |
$19 |
2017-09-30 |
$26 |
2017-06-30 |
$19 |
2017-03-31 |
$22 |
2016-12-31 |
$21 |
2016-09-30 |
$21 |
2016-06-30 |
$20 |
2016-03-31 |
$18 |
2015-12-31 |
$18 |
2015-09-30 |
$17 |
2015-06-30 |
$15 |
2015-03-31 |
$15 |
2014-12-31 |
$16 |
2014-09-30 |
$17 |
2014-06-30 |
$17 |
2014-03-31 |
$18 |
2013-12-31 |
$18 |
2013-09-30 |
$16 |
2013-06-30 |
$15 |
2013-03-31 |
$15 |
2012-12-31 |
$18 |
2012-09-30 |
$14 |
2012-06-30 |
$13 |
2012-03-31 |
$13 |
2011-12-31 |
$14 |
2011-09-30 |
$13 |
2011-06-30 |
$12 |
2011-03-31 |
$12 |
2010-12-31 |
$13 |
2010-09-30 |
$13 |
2010-06-30 |
$12 |
2010-03-31 |
$21 |
2009-12-31 |
$27 |
2009-09-30 |
$22 |
2009-06-30 |
$21 |
2009-03-31 |
$25 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical & Dental Supplies |
$1.312B |
$0.322B |
Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.
|